ABVC BioPharma Statistics Share Statistics ABVC BioPharma has 16.98M
shares outstanding. The number of shares has increased by 36.71%
in one year.
Shares Outstanding 16.98M Shares Change (YoY) 36.71% Shares Change (QoQ) 30.87% Owned by Institutions (%) 1.78% Shares Floating 15.6M Failed to Deliver (FTD) Shares 6,571 FTD / Avg. Volume 1.47%
Short Selling Information The latest short interest is 568.24K, so 3.35% of the outstanding
shares have been sold short.
Short Interest 568.24K Short % of Shares Out 3.35% Short % of Float 4% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.4 and the forward
PE ratio is 2.04.
ABVC BioPharma's PEG ratio is
0.02.
PE Ratio -1.4 Forward PE 2.04 PS Ratio 13.52 Forward PS 1.4 PB Ratio 5.62 P/FCF Ratio -3.81 PEG Ratio 0.02
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for ABVC BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.33,
with a Debt / Equity ratio of 1.98.
Current Ratio 0.33 Quick Ratio 0.33 Debt / Equity 1.98 Debt / EBITDA -0.56 Debt / FCF -1.34 Interest Coverage -5.7
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $31.85K Profits Per Employee $-306.44K Employee Count 16 Asset Turnover 0.07 Inventory Turnover n/a
Taxes Income Tax -111K Effective Tax Rate 2.07%
Stock Price Statistics The stock price has increased by 328.07% in the
last 52 weeks. The beta is 0.27, so ABVC BioPharma's
price volatility has been higher than the market average.
Beta 0.27 52-Week Price Change 328.07% 50-Day Moving Average 2.62 200-Day Moving Average 1.2 Relative Strength Index (RSI) 46.6 Average Volume (20 Days) 446,662
Income Statement In the last 12 months, ABVC BioPharma had revenue of 509.59K
and earned -4.9M
in profits. Earnings per share was -0.43.
Revenue 509.59K Gross Profit 508.83K Operating Income -4.71M Net Income -4.9M EBITDA -4.34M EBIT -4.54M Earnings Per Share (EPS) -0.43
Full Income Statement Balance Sheet The company has 248.38K in cash and 2.43M in
debt, giving a net cash position of -2.18M.
Cash & Cash Equivalents 248.38K Total Debt 2.43M Net Cash -2.18M Retained Earnings -68.95M Total Assets 14.88M Working Capital -5.21M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.81M
and capital expenditures 0, giving a free cash flow of -1.81M.
Operating Cash Flow -1.81M Capital Expenditures n/a Free Cash Flow -1.81M FCF Per Share -0.15
Full Cash Flow Statement Margins Gross margin is 99.85%, with operating and profit margins of -923.29% and -962.15%.
Gross Margin 99.85% Operating Margin -923.29% Pretax Margin -1053.79% Profit Margin -962.15% EBITDA Margin -852.26% EBIT Margin -923.29% FCF Margin -355.02%
Dividends & Yields ABVC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ABVC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 25, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Jul 25, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -3.42 Piotroski F-Score 2
